Common diabetes pill may hold key to stopping lung cancer before it starts
NCT ID NCT04931017
Summary
This study is testing if a widely used, safe diabetes medication called metformin can lower the chance of developing lung cancer. It involves 50 overweight former and current smokers who are at high risk for the disease. Researchers want to see if taking metformin daily for six months can 'reprogram' the immune system to be better at fighting off cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Research Centre
Vancouver, British Columbia, V5Z 1L3, Canada
-
Rocky Mountain Regional VA Medical Center
Aurora, Colorado, 80045, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University of British Columbia Hospital
Vancouver, British Columbia, V6T 2B5, Canada
Conditions
Explore the condition pages connected to this study.